Skip to content
2000
Volume 21, Issue 6
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Berberine (BBR) is a botanic alkaloid extracted from Coptis chinensis (Huanglian), which has various properties, compassing anti-hyperglycemia, anti-obesity, anti-inflammation, and improves insulin resistance, etc. Several researches have confirmed that BBR has effective actions in treating glycolipid metabolic abnormalities. BBR is also beneficial in regulating intestinal flora. Metabolic diseases are strongly associated with metabolic disorders, which are growing in the population and dramatically impacting human health, which also have been considered as a leading cause of diseases and death globally. This review is to evaluate the metabolic properties of BBR, and its potential application to the treatment of metabolic diseases by its effective actions on metabolic disorders.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530320666200910105612
2021-06-01
2025-05-10
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530320666200910105612
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test